Literature DB >> 9767424

Increased serum IgG1 levels and reduced numbers of B-1 B cells in DBA/2J mice.

K Tocce1, G Masters, C Rago, L Prior, K Suppiah, T Glysing-Jensen, S Leary, J Riggs.   

Abstract

B-cell heterogeneity studies have historically focused upon BALB/c mice and their derivatives. In contrast, the B cells of DBA/2J mice, a prototype strain for the study of the endogenous minor lymphocyte stimulatory (Mls) viral superantigen Mls-1a, have not been extensively investigated. DBA/2J B cells, by functioning as Mls-1a antigen-presenting cells, influence their own differentiation and diversity by inducing the proliferation and differentiation of specific CD4 T-cell subsets. In this report, the B cells of DBA/2J and BALB/c mice were compared for their ability to restore B-cell function in severe combined immunodeficient (SCID) recipients. Although spleen and bone marrow cells from these strains exhibited similar restoration of serum IgM production, the transfer of DBA/2J B cells into SCID mice led to greater IgG1 production. The peritoneal cells of DBA/2J mice consisted of a lower percentage of B-1 B cells and were less capable of restoring B-cell function after transfer into SCID recipients. These differences are discussed with respect to the possible role of viral superantigens in influencing B-lymphocyte diversity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767424      PMCID: PMC1364260          DOI: 10.1046/j.1365-2567.1998.00531.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Proliferative T cell anergy to MIs-1a does not correlate with in vivo tolerance.

Authors:  A Bandeira; J Mengel; O Burlen-Defranoux; A Coutinho
Journal:  Int Immunol       Date:  1991-09       Impact factor: 4.823

Review 2.  Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse.

Authors:  H Festenstein
Journal:  Transplant Rev       Date:  1973

3.  Adult bone marrow contains precursors for CD5+ B cells.

Authors:  C A Huang; C Henry; J Iacomini; T Imanishi-Kari; H H Wortis
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

4.  Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells.

Authors:  L Prior; S Pierson; R T Woodland; J Riggs
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

5.  Endogenous retroviral superantigen presentation by B cells induces the development of type 1 CD4+ T helper lymphocytes.

Authors:  K J Gollob; L Nagelkerken; R L Coffman
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

Review 6.  CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed.

Authors:  I Scher
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  The viral superantigen Mls-1a induces interferon-gamma secretion by specifically primed CD8+ cells but fails to trigger cytotoxicity.

Authors:  T Herrmann; G A Waanders; Y Chvatchko; H R MacDonald
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

Review 8.  Superantigens of mouse mammary tumor virus.

Authors:  H Acha-Orbea; H R MacDonald
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  The autologous mixed lymphocyte response: delayed T cell tolerance to B cells in XID mice.

Authors:  J E Riggs; F P Maurio; L G Prior; G R Sirken; M V Hobbs
Journal:  Cell Immunol       Date:  1994-09       Impact factor: 4.868

10.  Inhibition of murine B1 lymphocytes by interleukin-12.

Authors:  L A Vogel; T L Lester; V H Van Cleave; D W Metzger
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.